跳至主要内容
临床试验/NCT01015937
NCT01015937已完成不适用

Effect of Turmeric on Diabetic Nephropathy

Shaheed Faghihi Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1

研究概览

简要总结

The purpose of this study is to investigate whether turmeric is effective in improvement of diabetic nephropathy and in decrease in the amount of proteinuria and cytokine levels.

详细描述

Diabetic nephropathy is leading cause of ESRF that many therapy recommended for it. In this study, we investigate effect of turmeric on diabetic nephropathy, thus we selected diabetic nephropathy patients and divided them into 2 groups. One group received turmeric + ACE inhibitor + Angiotensin II receptor blocker (ARB) and the second group received only ACE inhibitor + ARB.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diabetic nephropathy
  • more than 300 mg proteinuria/day
  • age more than 18 years old

排除标准

  • DM type 1

研究组 & 干预措施

Turmeric

Active Comparator

diabetic nephropathy patient

more than 300 mg/proteinuria

干预措施: Turmeric extract (Drug)

ACE inhibitor + ATI blocker

Active Comparator

diabetic nephropathy

more than 300 mg/day proteinuria

干预措施: Turmeric extract (Drug)

ACE inhibitor + ATI blocker

Active Comparator

diabetic nephropathy

more than 300 mg/day proteinuria

干预措施: Angiotensin-converting enzyme (ACE) inhibitor + Angiotensin-II type 1 receptor (ATI) blocker (Drug)

研究者

发起方
Shaheed Faghihi Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验